Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience

Meningococcal diseases are serious threats to global health, and new vaccines specifically tailored to meet the age-related needs of various geographical areas are required. This paper focuses on the meningococcal conjugate vaccines developed by GSK Biologicals. Two combined conjugate vaccines were...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Jacqueline M., Mesaros, Narcisa, Van Der Wielen, Marie, Baine, Yaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170757/
https://www.ncbi.nlm.nih.gov/pubmed/21991444
http://dx.doi.org/10.4061/2011/846756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170757/
https://www.ncbi.nlm.nih.gov/pubmed/21991444
http://dx.doi.org/10.4061/2011/846756

Ejemplares similares